Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

340B Compliance: HRSA Outlines Use Of Extra Funding For 2014

This article was originally published in The Pink Sheet Daily

Executive Summary

The $6 million Congress appropriated to the Health Resources and Services Administration to boost its oversight of compliance with 340B drug discount program rules is being used to analyze information from recent program integrity efforts, conduct additional audits and install IT systems that will allow it to track compliance by health care providers and drug manufacturers.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS077037

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel